Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis

Journal Title: UNKNOWN - Year 2019, Vol 25, Issue 2

Abstract

.

Authors and Affiliations

Halil Önder

Keywords

Related Articles

Mirror Imaginary Movement Disorder and Pachygyria Association: Case Report

Mirror imaginary movement disorders are a group of syndromes characterized by automatic reflex mimicking of voluntary movements on the contralateral side. Two hypotheses for these symptoms are currently accepted: abnorma...

Quality of Life in Patients with Drug Resistant Epilepsy

Objective: Quality of life (QOL) is considered the main outcome in epilepsy trials, but in developing countries such as India, data available regarding QOL in drug-resistant epilepsy (DRE) are scarce. The present study w...

Assessment of Serum Uric Acid Levels According to Sex and Stage for Patients with Alzheimer-type Dementia

Objective: The aim of this study was to identify serum uric acid (UA) concentrations according to disease stage in patients with Alzheimer-type dementia (AD), and to collect data related to the hypothesis that oxidative...

Download PDF file
  • EP ID EP581190
  • DOI 10.4274/tnd.galenos.2019.05925
  • Views 94
  • Downloads 0

How To Cite

Halil Önder (2019). Subcutaneous Ofatumumab in Patients with Relapsing-remitting Multiple Sclerosis. UNKNOWN, 25(2), 105-106. https://europub.co.uk/articles/-A-581190